
Lupin Ltd.
1,953.20-6.8 (-0.35%)
14 Oct, 12:00 AM
Stock News
Lupin Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
Moneycontrol
Lupin, Sun Pharma, Zydus Lifesciences gain up to 1.5% as Nomura retains 'Buy' ratings amid pharma growth surge
Lupin Limited advanced 1.31% to Rs 1,962.30 after Nomura retained its Buy rating on the stock. Nomura highlighted strong Indian Pharmaceutical Market growth of 13.5% year-on-year in September and said Lupin recorded growth of more than 15% in September.
9th Oct '26 5:36 am
Read full article on moneycontrol.com